Alyeska Investment Group’s CVS Health CVS Stock Holding History

Alyeska Investment Group’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$174M	Buy	+1,685,440	New	+$150M	0.45%	50
2026 Q1	–	Sell	-795,000	Closed	-$63.1M	–	643
2025 Q4	$63.1M	Buy	+795,000	New	+$62.7M	0.18%	151
2024 Q3	–	Sell	-1,014,191	Closed	-$59.9M	–	567
2024 Q2	$59.9M	Buy	+1,014,191	New	+$63.4M	0.34%	98
2019 Q1	–	Sell	-10,000	Closed	-$655K	–	392
2018 Q4	$655K	Buy	+10,000	New	+$746K	0.01%	324
2015 Q1	–	Sell	-17,311	Closed	-$1.67M	–	505
2014 Q4	$1.67M	Buy	+17,311	New	+$1.53M	0.03%	355

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Alyeska Investment Group's CVS Position: Q2 2026 in Review

Alyeska Investment Group opened a new position in CVS Health (CVS) in Q2 2026: 1,685,440 shares worth $174M. The stake represents 0.45% of the portfolio and ranks #50 among its holdings. This is a return to the name: Alyeska Investment Group previously reported a position in CVS as recently as Q4 2025.

Alyeska Investment Group first reported a position in CVS in Q4 2014 and has held it in 5 quarters since. 2,062 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Alyeska Investment Group held 1,685,440 shares of CVS Health worth $174M as of Q2 2026.
CVS Health was a new Alyeska Investment Group position in Q2 2026.
CVS Health made up 0.45% of Alyeska Investment Group's portfolio in Q2 2026, its #50 holding.
Alyeska Investment Group first reported a position in CVS Health in Q4 2014 and has held it in 5 quarters since.
2,062 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.